ABT-263 (Navitoclax)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for ABT-263 (Navitoclax), covering 2017-11-21 to 2017-11-21. Get the full timeline:
Most recent: Clinical Trial Update: Safety Study of ABT-263 in Combination With Gemzar (Gemcitabine) in Subjects With Solid Tumors [Phase 1]